| Datum |
Zeit |
Quelle |
Überschrift |
|---|
| 30.4.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising.. |
| 18.4.2024 | 14:32 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from.. |
| 18.4.2024 | 14:30 | PRNUS | NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million.. |
| 17.4.2024 | 22:45 | PRNUS | NRx Pharmaceuticals, Inc. Announces Proposed Underwritten.. |
| 17.4.2024 | 14:30 | PRNUS | NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data.. |
| 15.4.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of.. |
| 08.4.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of.. |
| 01.4.2024 | 14:28 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and.. |
| 28.3.2024 | 13:03 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth.. |
| 28.3.2024 | 13:00 | PRNUS | NRx Pharmaceuticals Announces Reverse Stock Split to.. |
| 26.3.2024 | 21:03 | PRNUS | UPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth.. |
| 25.3.2024 | 13:30 | PRNUS | NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan.. |
| 21.3.2024 | 21:02 | PRNUS | NRx Pharmaceuticals to Report Fourth Quarter and Full Year.. |
| 21.3.2024 | 18:57 | PRNUS | NRx Pharmaceuticals Announces Results of the Vote Held.. |
| 12.3.2024 | 12:49 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to.. |
| 11.3.2024 | 22:16 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 11.3.2024 | 13:30 | PRNUS | NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of.. |
| 06.3.2024 | 22:08 | EDGAR2 | Form 8-K - Current report |
| 04.3.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,.. |
| 01.3.2024 | 14:30 | PRNUS | NRx Pharmaceuticals Announces Definitive Purchase Agreement.. |
| 28.2.2024 | 23:09 | EDGAR2 | Form 8-K - Current report |
| 28.2.2024 | 16:40 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 27.2.2024 | 16:49 | PRNUS | /C O R R E C T I O N -- NRx Pharmaceuticals, Inc./ |
| 27.2.2024 | 14:54 | PRNUS | NRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million.. |
| 26.2.2024 | 23:15 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 26.2.2024 | 22:01 | PRNUS | NRx Pharmaceuticals, Inc. Announces Proposed Underwritten.. |
| 26.2.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE.. |
| 20.2.2024 | 14:30 | PRNUS | NRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE.. |
| 14.2.2024 | 22:30 | EDGAR2 | Form 8-K - Current report |
| 14.2.2024 | 12:03 | EDGAR2 | Form 8-K - Current report |
| 12.2.2024 | 14:30 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance.. |
| 09.2.2024 | 14:30 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by.. |
| 05.2.2024 | 12:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the.. |
| 02.2.2024 | 22:37 | EDGAR2 | Form 8-K - Current report |
| 23.1.2024 | 22:16 | EDGAR2 | Form 8-K - Current report |
| 22.1.2024 | 12:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces.. |
| 17.1.2024 | 12:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt.. |
| 17.1.2024 | 00:36 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 16.1.2024 | 13:25 | DJN | NRx Pharmaceuticals Gets Fast-Track Designation for NRX-101.. |
| 16.1.2024 | 12:48 | PRNUS | NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA.. |
| 02.1.2024 | 14:45 | PRNUS | NRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote.. |
| 02.1.2024 | 12:48 | PRNUS | NRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance.. |
| 29.12.2023 | 22:30 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 29.12.2023 | 22:15 | EDGAR2 | Form 8-K - Current report |
| 27.12.2023 | 12:48 | PRNUS | NRx Pharmaceuticals Announces the Election of Janet.. |
| 21.12.2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 19.12.2023 | 14:15 | PRNUS | NRx Pharmaceuticals Announces Signing of a Data and.. |
| 18.12.2023 | 12:48 | PRNUS | NRx Pharmaceuticals Announces FDA Clearance of its.. |
| 13.12.2023 | 22:02 | PRNUS | NRx Pharmaceuticals Provides Notice of Annual Meeting of.. |
| 11.12.2023 | 12:48 | PRNUS | NRx Pharmaceuticals to Participate in LifeSci Corporate.. |
Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
